Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease-Reference-Cited by-同舟云学术

Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease

Published:2023-01 Issue:1 Volume:98 Page:88-99
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Chang Hung-Yu,Lin Chun-Cheng,Chao Chieh-Ju^ORCID,Lin Yi-Cheng^ORCID,Wang Yao-Chang,Liao Chia-Te,Huang Jin-Long^ORCID,Lee Ying-Hsiang,Huang Chun-Yao,Chien Li-Nien,Hsu Chien-Yi^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Heart disease and stroke statistics-2020 update: a report from the American Heart Association;Virani;Circulation,2020

2. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey;van Deursen;Eur J Heart Fail,2014

3. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure;Hillege;Circulation,2006

4. The kidney in heart failure: an update;Damman;Eur Heart J,2015

5. Management of heart failure in advancing CKD: core curriculum 2018;House;Am J Kidney Dis,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of angiotensin receptor–neprilysin inhibition in heart failure patients with end‐stage kidney disease on maintenance dialysis: A systematic review and meta‐analysis;European Journal of Heart Failure;2024-09-09

2. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

3. Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis;Frontiers in Cardiovascular Medicine;2024-07-22

4. Bridging the STRONG Gap: Call to Optimize Heart Failure Treatment After Hospitalization in Women and Men in Taiwan;The American Journal of Cardiology;2024-07

5. The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review;Indian Heart Journal;2024-07